000			02178nam a22003497a 4500
008			240117s20232023 xxu||||| |||| 00| 0 eng d
022			_a2772-9303
024			_aPMC11308238 [pmc]
024			_aS2772-9303(23)00521-5 [pii]
040			_aOvid MEDLINE(R)
099			_a39131652
245			_aMitral Regurgitation in Female Patients: Sex Differences and Disparities. [Review]
251			_aJournal of the Society for Cardiovascular Angiography & Interventions. 2(4):101032, 2023 Jul-Aug.
252			_aJ Soc Cardiovasc Angiogr Interv. 2(4):101032, 2023 Jul-Aug.
253			_aJournal of the Society for Cardiovascular Angiography & Interventions
260			_c2023
260			_fFY2024
260			_p2023 Jul-Aug
265			_sepublish
265			_tPubMed-not-MEDLINE
266			_z2024/08/12 06:14
520			_aMitral regurgitation is the most common valvular disease, particularly in older adults. Recent literature has consistently supported that there are significant differences in mitral regurgitation outcomes between male and female patients and that this is likely multifactorial. Numerous sex differences in anatomy and pathophysiology may play a role in delayed diagnoses, referrals, and treatments for female patients. Despite the recognition of these discrepancies in the literature, many guidelines that steer clinical care do not incorporate these factors into society recommendations. Identifying and validating sex-specific diagnostic parameters and increasing the representation of female patients in trials of new mitral regurgitation treatment modalities are key factors in improving outcomes for female patients. Copyright © 2023 The Author(s).
546			_aEnglish
651			_aMedStar Washington Hospital Center
656			_aCardiovascular Disease Fellowship
657			_aJournal Article
657			_aReview
700			_aMay, Megan _bMWHC _cCardiovascular Disease Fellowship _dMD
790			_aOcher R , May M , Labin J , Shah J , Horwich T , Watson KE , Yang EH , Calfon Press MA
856			_uhttps://dx.doi.org/10.1016/j.jscai.2023.101032 _zhttps://dx.doi.org/10.1016/j.jscai.2023.101032
942			_cART _dArticle
999			_c14629 _d14629